The investigators will conduct a pilot randomized controlled trial (RCT) study of 100 people with a history of opioid use disorder releasing to WA Department of Corrections (DOC) community corrections supervision in King County. Half of the subjects will receive treatment as usual (e.g. referral to treatment or outpatient drug counseling by DOC community corrections staff) and half will receive 6 months of intervention. The intervention involves treatment decision making, in which the study interventionists help subjects understand treatment choices, decide on the treatment that is best for them, get enrolled in treatment and remain in treatment. The study does not provide treatment, but works with treatment providers to facilitate access to care. The aims of this study are to determine: 1) whether study procedures can be implemented with as designed, 2) whether offenders can be enrolled and maintained in the study, 3) which medications/treatment options subjects select and their experiences and satisfaction with the interventions, and 4) preliminary intervention effect size on outcomes of interest including recidivism, drug use, hospitalization, and treatment enrollment and retention.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
17
Subjects in the intervention arm will begin a discussion with the interventionist about whether they are interested in treatment and medication choices for opioid use disorder. The interventionist will use a decision tool informed by the Substance Abuse and Mental Health Services Administration (SAMSHA) guide to medication assisted treatment in order to help make an informed decision about treatment choices. Once a decision is reached, the Treatment Navigator will communicate with the subject periodically to assist with entering treatment and help with locating other social services as needed within the community. The Treatment Navigator will emphasize getting into treatment as quickly as possible once a decision is made. The Treatment Navigator and the subject will continue communicating throughout the 6 month study period. Subjects will also receive overdose education and be offered take-home naloxone.
Subjects in the control arm will receive referrals from Department of Corrections (DOC) staff for treatment per DOC protocols. Subjects will not receive any treatment navigation or treatment decision making. Subjects will also receive overdose education and be offered take-home naloxone.
DOC Community Field Office
Auburn, Washington, United States
DOC Community Field Office
Burien, Washington, United States
DOC Community Field Office
Federal Way, Washington, United States
DOC Community Field Office
Kent, Washington, United States
DOC Community Field Office
Renton, Washington, United States
Intervention Feasibility
The number of potentially eligible subjects self-referred or identified by Department of Corrections whom study staff were able to contact, screen, determine to be eligible and enroll in the study at Community Corrections facilities.
Time frame: 6 months
Criminal Activity
The rate of arrests, charges and/or convictions for the comparison group versus the intervention group accounting for various potential residual confounders.
Time frame: 1 month
Criminal Activity
The rate of arrests, charges and/or convictions for the comparison group versus the intervention group accounting for various potential residual confounders.
Time frame: 6 months
Hospitalizations
The rate of hospitalizations for the comparison group versus the intervention group accounting for various potential residual confounders.
Time frame: 1 month
Hospitalizations
The rate of hospitalizations for the comparison group versus the intervention group accounting for various potential residual confounders.
Time frame: 6 months
Treatment Enrollment
The rate of treatment enrollment for the comparison group versus the intervention group accounting for various potential residual confounders.
Time frame: 1 month
Treatment Enrollment
The rate of treatment enrollment for the comparison group versus the intervention group accounting for various potential residual confounders.
Time frame: 6 months
Relapse Prevention Medication Prescriptions
The rate of medication initiation for the comparison group versus the intervention group accounting for various potential residual confounders.
Time frame: 1 month
Relapse Prevention Medication Prescriptions
The rate of medication initiation for the comparison group versus the intervention group accounting for various potential residual confounders.
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.